Posted By: Constantinos T Sofocleous, MD, PhD, FSIR, FCIRSE
Fri Apr 24th, 2020
Cancer care during the pandemic requires assessment of several factors that are specific to each patient as well as the curve of the pandemic in a particular location and the infrastructure capabilities at the center offering care. As a general approach, we consider continuation of cancer care unles
The COVID-19 pandemic has greatly impacted the entire patient experience in interventional oncology at our institution. This goes beyond the known infected patients or those under investigation with the newly expected, necessary personal protective equipment (PPE) and safety precautions taken. It a
“Why are you bringing all these cancer patients into the hospital and putting us all at risk?” asked one of my non-IO colleagues. An undiagnosed COVID patient brought in that day for an extended procedure resulted in losing six staff to a week-long quarantine.
As we all struggle to provide optimal care for our patients during these unprecedented times, it is clear that the pandemic has affected us all in different ways: with differing timing, magnitude, resource constraints, and local policies.
Given these circumstances, it is difficult to develop broadl
The Society of Interventional Oncology NCCN Committee spearheaded an effort in 2019 to provide input into the 2020 update of Kidney Cancer NCCN guidelines. SIO brought our RCC task force together and helped us through the specifics of the NCCN submission process.
